全球贾第虫病治疗市场 - 行业趋势和 2029 年预测

市场分析与洞察全球贾第虫病治疗市场

预计在 2022 年至 2029 年的预测期内，贾第虫病治疗市场将以 6.80% 的速度增长。Data Bridge Market Research 关于贾第虫病治疗市场的报告提供了有关预测期内预计会盛行的各种因素的分析和见解，同时提供了它们对市场增长的影响。全球慢性病患病率的上升正在加速贾第虫病治疗市场的增长。

贾第虫病，又称海狸热，是指由十二指肠贾第虫引起的一种原虫感染。这种原虫也被称为蓝氏贾第虫和肠贾第虫。大约 10% 的感染贾第虫的人往往没有任何症状。这种疾病的常见症状包括腹痛、体重减轻和腹泻。这通常是由于食物和水受到污染而发生的。

全球水污染水平的上升是推动贾第虫病治疗市场增长的主要因素之一。贾第虫病在人群中的患病率增加，尤其是在儿童及其父母中，因为儿童换尿布会增加感染风险，这加速了市场的增长。发展中国家新生儿数量的增加以及不卫生的水和食物的消费以及被动物和人类粪便污染的水源进一步影响了市场。此外，医疗保健支出的激增、技术的发展、意识的提高、缺乏卫生习惯以及原生动物感染病例的增加对贾第虫病治疗市场产生了积极影响。此外，与贾第虫病治疗相关的持续研究活动和有利的监管环境为市场参与者在 2022 年至 2029 年的预测期内带来了盈利机会。

另一方面，使用抗原生动物药物的副作用预计将阻碍市场增长。预计在 2022-2029 年的预测期内，对贾第虫病治疗的无知将对贾第虫病治疗市场构成挑战。

This giardiasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info giardiasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Giardiasis Treatment Market Scope and Market Size

The giardiasis treatment market is segmented on the basis of drug class, drug type, end-users and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of drug class, the giardiasis treatment market is segmented into amebicides, anthelmintic and others.
• On the basis of drug type, the giardiasis treatment market is segmented into branded and generic.
• On the basis of end-users, the giardiasis treatment market is segmented into hospitals, homecare, specialty clinics and others.
• On the basis of distribution channel, the giardiasis treatment market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.

Giardiasis Treatment Market Country Level Analysis

The giardiasis treatment market is segmented on the basis of drug class, drug type, end-users and distribution channel.

The countries covered in the global giardiasis treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Asia-Pacific dominates the giardiasis treatment market due to the presence of the large population within the region. Europe is expected to witness high growth during the forecast period of 2021 to 2028 because of the increase in awareness in the region.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

患者流行病学分析

贾第虫病治疗市场还为您提供详细的市场分析，用于患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响，以创建更稳健、更队列的多元统计模型，用于预测增长期的市场。

竞争格局和贾第虫病治疗市场份额分析

贾第虫病治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司关注的贾第虫病治疗市场有关。

贾第虫病治疗市场报告中的一些主要参与者包括 F. Hoffmann-La Roche Ltd、Mylan NV、Teva Pharmaceuticals Industries Ltd、Hikma Pharmaceuticals PLC、Sun Pharmaceuticals Industries Ltd、Amneal Pharmaceuticals LLC、Merck & Co., Inc.、Alkem Labs Ltd 和 Cipla Inc. 等。

SKU-24744